Effect of sour tea (Hibiscus sabdariffa L.) on arterial hypertension: A systematic review and meta-analysis of randomized controlled trials

Journal of Hypertension

Volumn 33, Issue 6, 2015, Pages 1119-1127

  Serban, Corina ^a   Sahebkar, Amirhossein ^b,c   Ursoniu, Sorin ^a   Andrica, Florina ^a   Banach, Maciej ^d  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

antioxidants; arterial hypertension; flavonoids; Hibiscus sabdariffa L.; polyphenols

Indexed keywords

ANTIHYPERTENSIVE AGENT; CAPTOPRIL; HIBISCUS SABDARIFFA EXTRACT; LISINOPRIL; PLACEBO; PLANT EXTRACT;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DRUG EFFICACY; EFFECT SIZE; HIBISCUS SABDARIFFA; HUMAN; HYPERTENSION; META ANALYSIS; NONHUMAN; PARALLEL DESIGN; PRIORITY JOURNAL; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; ARTERIAL PRESSURE; DRUG EFFECTS; FEMALE; HIBISCUS; MALE; PHYTOTHERAPY;

ANTIHYPERTENSIVE AGENTS; ARTERIAL PRESSURE; FEMALE; HIBISCUS; HUMANS; HYPERTENSION; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84929386175     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000585     Document Type: Article

References (56)

1. Bielecka-Dabrowa A, Aronow WS, Rysz J, Banach M. The rise and fall of hypertension: lessons learned from Eastern Europe. Curr Cardiovasc Risk Rep 2011; 5:174-179.
2. Gluba A, Bielecka-Dabrowa A, Mikhailidis DP, Wong ND, Franklin SS, Rysz J, et al. An update on biomarkers of heart failure in hypertensive patients. J Hypertens 2012; 30:1681-1689.
3. Haji Faraji M, Haji Tarkhani A. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J Ethnopharmacol 1999; 65:231-236.
4. Gurrola-Diaz CM, Garcia-Lopez PM, Sanchez-Enriquez S, Troyo-Sanroman R, Andrade-Gonzalez I, Gomez-Leyva JF. Effects of Hibiscus sabdariffa extract powder and preventive treatment (diet) on the lipid profiles of patients with metabolic syndrome (MeSy). Phytomedicine 2010; 17:500-505.
5. Aziz Z, Wong SY, Chong NJ. Effects of Hibiscus sabdariffa L. on serum lipids: a systematic review and meta-analysis. J Ethnopharmacol 2013; 150:442-450.
6. Chang HC, Peng CH, Yeh DM, Kao ES, Wang CJ. Hibiscus sabdariffa extract inhibits obesity and fat accumulation, and improves liver steatosis in humans. Food Function 2014; 5:734-739.
7. Joven J, March I, Espinel E, Fernandez-Arroyo S, Rodriguez-Gallego E, Aragones G, et al. Hibiscus sabdariffa extract lowers blood pressure and improves endothelial function. Mol Nutr Food Res 2014; 58:1374-1378.
8. Wahabi HA, Alansary LA, Al-Sabban AH, Glasziuo P. The effectiveness of Hibiscus sabdariffa in the treatment of hypertension: a systematic review. Phytomedicine 2010; 17:83-86.
9. McKay DL, Chen CY, Saltzman E, Blumberg JB. Hibiscus sabdariffa L. tea (tisane) lowers blood pressure in prehypertensive and mildly hypertensive adults. J Nutr 2010; 140:298-303.
10. Guardiola S, Mach N. Therapeutic potential of Hibiscus sabdariffa: a review of the scientific evidence. Endocrinologia y nutricion 2014; 61:274-295.
11. KimJK, So H, Youn MJ, KimHJ, KimY, Park C, et al. Hibiscus sabdariffa L. water extract inhibits the adipocyte differentiation through the PI3-K and MAPK pathway. J Ethnopharmacol 2007; 114:260-267.
12. Chen CC, Hsu JD, Wang SF, Chiang HC, Yang MY, Kao ES, et al. Hibiscus sabdariffa extract inhibits the development of atherosclerosis in cholesterol-fed rabbits. J Agric Food Chem 2003; 51:5472-5477.
13. Sindi HA, Marshall LJ, Morgan MR. Comparative chemical and biochemical analysis of extracts of Hibiscus sabdariffa. Food Chem 2014; 164C:23-29.
14. Patel S. Hibiscus sabdariffa: an ideal yet under-exploited candidate for nutraceutical applications. Biomed Prevent Nutr 2014; 4:23-27.
15. Herrera-Arellano A, Flores-Romero S, Chavez-Soto MA, Tortoriello J. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine 2004; 11:375-382.
16. Herrera-Arellano A, Miranda-Sanchez J, Avila-Castro P, Herrera-Alvarez S, Jimenez-Ferrer JE, Zamilpa A, et al. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. A randomized, double-blind, lisinoprilcontrolled clinical trial. Planta Medica 2007; 73:6-12.
17. Mojiminiyi FB, Dikko M, Muhammad BY, Ojobor PD, Ajagbonna OP, Okolo RU, et al. Antihypertensive effect of an aqueous extract of the calyx of Hibiscus sabdariffa. Fitoterapia 2007; 78:292-297.
18. Mojiminiyi FB, Audu Z, Etuk EU, Ajagbonna OP. Attenuation of saltinduced hypertension by aqueous calyx extract of Hibiscus sabdariffa. Nigerian J Physiol Sci 2012; 27:195-200.
19. Hopkins AL, Lamm MG, Funk JL, Ritenbaugh C. Hibiscus sabdariffa L. in the treatment of hypertension and hyperlipidemia: a comprehensive review of animal and human studies. Fitoterapia 2013; 85:84-94.
20. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8:336-341.
21. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17:1-12.
22. Higgins J, Thompson S, Deeks J, Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002; 7:51-61.
23. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res 2014; 28:633-642.
24. Sahebkar A. Does PPARgamma2 gene Pro12Ala polymorphism affect nonalcoholic fatty liver disease risk? Evidence from a meta-analysis. DNA Cell Biol 2013; 32:188-198.
25. Sahebkar A. Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 2013; 71:822-835.
26. Borenstein M, Higgins JP. Meta-analysis and subgroups. Prevent Sci 2013; 14:134-143.
27. Bolanos Diaz R, Calderon Cahua M. Introduction to traditional metaanalysis. Revista de gastroenterologia del Peru 2014; 34:45-51.
28. Mozaffari-Khosravi H, Jalali-Khanabadi BA, Afkhami-Ardekani M, Fatehi F, Noori-Shadkam M. The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes. J Human Hypertens 2009; 23:48-54.
29. Mozaffari-Khosravi H, Ahadi Z, Barzegar K. The effect of green tea and sour tea on blood pressure of patients with type 2 diabetes: a randomized clinical trial. J Diet Suppl 2013; 10:105-115.
30. Anon. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997; 157:2413-2446.
31. Inuwa I, Ali BH, Al-Lawati I, Beegam S, Ziada A, Blunden G. Long-term ingestion of Hibiscus sabdariffa calyx extract enhances myocardial capillarization in the spontaneously hypertensive rat. Exp Biol Med 2012; 237:563-569.
32. Ajay M, Chai HJ, Mustafa AM, Gilani AH, Mustafa MR. Mechanisms of the antihypertensive effect of Hibiscus sabdariffa L. calyces. J Ethnopharmacol 2007; 109:388-393.
33. Sarr M, Ngom S, Kane MO, Wele A, Diop D, Sarr B, et al. In vitro vasorelaxation mechanisms of bioactive compounds extracted from Hibiscus sabdariffa on rat thoracic aorta. Nutr Metab 2009; 6:45.
34. Ojeda D, Jimenez-Ferrer E, Zamilpa A, Herrera-Arellano A, Tortoriello J, Alvarez L. Inhibition of angiotensin converting enzyme (ACE) activity by the anthocyanins delphinidin-and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa. J Ethnopharmacol 2010; 127:7-10.
35. Christian K, Nair M, Jackson J. Antioxidant and cyclooxygenase inhibitory activity of sorrel (Hibiscus sabdariffa). J Food Compos Analysis 2006; 19:778-783.
36. Mckay D. Can hibiscus tea lower blood pressure. Agro Food Industry Hi-Tech 2009; 20:40-42.
37. Perez-Vizcaino F, Duarte J, Jimenez R, Santos-Buelga C, Osuna A. Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 2009; 61:67-75.
38. Mackraj I, Govender T, Ramesar S. The antihypertensive effects of quercetin in a salt-sensitive model of hypertension. J Cardiovasc Pharmacol 2008; 51:239-245.
39. Duarte J, Pérez-Palencia R, Vargas F, Angeles Ocete M, Pérez-Vizcaino F, Zarzuelo A, et al. Antihypertensive effects of the flavonoid quercetin in spontaneously hypertensive rats. Br J Pharmacol 2001; 133:117-124.
40. Edwards RL, Lyon T, Litwin SE, Rabovsky A, Symons JD, Jalili T. Quercetin reduces blood pressure in hypertensive subjects. J Nutr 2007; 137:2405-2411.
41. Lee M-J, Chou F-P, Tseng T-H, Hsieh M-H, Lin M-C, Wang C-J. Hibiscus protocatechuic acid or esculetin can inhibit oxidative LDL induced by either copper ion or nitric oxide donor. J Agric Food Chem 2002; 50:2130-2136.
42. Larson AJ, Symons JD, Jalili T. Therapeutic potential of quercetin to decrease blood pressure: review of efficacy and mechanisms. Adv Nutr 2012; 3:39-46.
43. Wahabi H, Alansary L, Al-Sabban A, Glasziuo P. The effectiveness of Hibiscus sabdariffa in the treatment of hypertension: a systematic review. Phytomedicine 2010; 17:83-86.
44. Gonzalez J, Valls N, Brito R, Rodrigo R. Essential hypertension and oxidative stress: new insights. World J Cardiol 2014; 6:353-366.
45. Crowley SD. The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension. Antioxid Redox Signal 2014; 20:102-120.
46. Frank T, Netzel G, Kammerer DR, Carle R, Kler A, Kriesl E, et al. Consumption of Hibiscus sabdariffa L. aqueous extract and its impact on systemic antioxidant potential in healthy subjects. J Sci Food Agric 2012; 92:2207-2218.
47. Fernandez-Arroyo S, Herranz-Lopez M, Beltran-Debon R, Borras-Linares I, Barrajon-Catalan E, Joven J, et al. Bioavailability study of a polyphenol-enriched extract from Hibiscus sabdariffa in rats and associated antioxidant status. Mol Nutr Food Res 2012; 56:1590-1595.
48. Ajiboye TO, Salawu NA, Yakubu MT, Oladiji AT, Akanji MA, Okogun JI. Antioxidant and drug detoxification potentials of Hibiscus sabdariffa anthocyanin extract. Drug Chem Toxicol 2011; 34:109-115.
49. Galleano M, Pechanova O, Fraga CG. Hypertension, nitric oxide, oxidants, and dietary plant polyphenols. Curr Pharmaceut Biotechnol 2010; 11:837-848.
50. Onyenekwe PC, Ajani EO, Ameh DA, Gamaniel KS. Antihypertensive effect of roselle (Hibiscus sabdariffa) calyx infusion in spontaneously hypertensive rats and a comparison of its toxicity with that in Wistar rats. Cell Biochem Function 1999; 17:199-206.
51. Fakeye TO, Pal A, Bawankule DU, Yadav NP, Khanuja SP. Toxic effects of oral administration of extracts of dried calyx of Hibiscus sabdariffa Linn. (Malvaceae). Phytother Res 2009; 23:412-416.
52. Ndu OO, Nworu CS, Ehiemere CO, Ndukwe NC, Ochiogu IS. Herb-drug interaction between the extract of Hibiscus sabdariffa L. and hydrochlorothiazide in experimental animals. J Med Food 2011; 14:640-644.
53. Banach M, Serban C, Aronow WS, Rysz J, Dragan S, Lerma EV, et al. Lipid, blood pressure and kidney update 2013. Int Urol Nephrol 2014; 46:947-961.
54. Michalska M, Zanchetti A, Wong N, Malyszko J, Rysz J, Banach M. Patients with prehypertension: do we have enough evidence to treat them? Curr Vasc Pharmacol 2014; 12:586-597.
55. Sleight P, Yusuf S, Pogue J, Tsuyuki R, Diaz R, Probstfield J. Bloodpressure reduction and cardiovascular risk in HOPE study. Lancet 2001; 358:2130-2131.
56. Caligiuri SP, Edel AL, Aliani M, Pierce GN. Flaxseed for hypertension: implications for blood pressure regulation. Curr Hypertens Rep 2014; 16:1-13.